Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology

Despite RT-PCR confirmed COVID-19, specific antibodies to SARS-CoV-2 spike are undetectable in serum in approximately 10% of convalescent patients after mild disease course. This raises the question of induction and persistence of SARS-CoV-2-reactive T cells in these convalescent individuals. Using...

Full description

Bibliographic Details
Main Authors:	Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Franziska Sotzny, Sandra Bauer, Christian Drosten, Hans-Dieter Volk, Carmen Scheibenbogen, Leif G. Hanitsch
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Immunology
Subjects:	coronavirus disease 2019 (COVID-19) T cell response seronegative antibody response human endemic coronavirus 229E (HCoV-229E) human endemic coronavirus OC43 (HCoV-OC43)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.687449/full

Similar Items

Coronaviruses in Children, Greece
by: Anna Papa, et al.
Published: (2007-06-01)

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1
by: Nehemya Friedman, et al.
Published: (2018-09-01)

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
by: Haiyan Yan, et al.
Published: (2021-09-01)

Co-circulation of Four Human Coronaviruses (HCoVs) in Queensland Children with Acute Respiratory Tract Illnesses in 2004
by: Theo P. Sloots, et al.
Published: (2012-04-01)

Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
by: Cheng-Wei Yang, et al.
Published: (2020-12-01)

Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes
by: Nathalie Kin, et al.
Published: (2015-05-01)

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
by: Uri Greenbaum, et al.
Published: (2021-04-01)

Genetic Characterisation and Comparison of Three Human Coronaviruses (HKU1, OC43, 229E) from Patients and Bovine Coronavirus (BCoV) from Cattle with Respiratory Disease in Slovenia
by: Monika Jevšnik Virant, et al.
Published: (2021-04-01)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
by: Sophie Steiner, et al.
Published: (2020-12-01)

Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells
by: Jung Sun Min, et al.
Published: (2020-07-01)

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2
by: Johanna Signer, et al.
Published: (2020-09-01)

The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients
by: Alessandro Marcello, et al.
Published: (2020-09-01)

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro
by: Sébastien Pasquereau, et al.
Published: (2021-02-01)

Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?
by: Pier Paolo Piccaluga, et al.
Published: (2021-01-01)

The human coronavirus HCoV-229E S-protein structure and receptor binding
by: Zhijie Li, et al.
Published: (2019-10-01)

Repurposing old drugs as antiviral agents for coronaviruses
by: Cheng-Wei Yang, et al.
Published: (2020-08-01)

A high-throughput drug screening strategy against coronaviruses
by: Jia Liu, et al.
Published: (2021-02-01)

Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication
by: Bingpeng Yan, et al.
Published: (2019-01-01)

Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
by: Sabina Andreu, et al.
Published: (2021-03-01)

In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229
by: Lior Chatow, et al.
Published: (2021-03-01)

Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity
by: Mackenzie E. Coden, et al.
Published: (2021-06-01)

Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains
by: Shuai Xia, et al.
Published: (2018-02-01)

First Detection of Human Coronavirus HKU1 in Greece, in an Immunocompromised Patient With Severe Lower Respiratory Tract Infection
by: Vasiliki Epameinondas Georgakopoulou, et al.
Published: (2021-05-01)

Caractérisation de la protéine S du coronavirus humain 229E
by: Bonnin, Ariane
Published: (2018)

Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E)
by: Keykavous Parang, et al.
Published: (2020-05-01)

CD4+ T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
by: Pavla Taborska, et al.
Published: (2021-05-01)

Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic
by: Natalie C. Marshall, et al.
Published: (2021-05-01)

Evaluation of Antiviral, Antibacterial and Antiproliferative Activities of the Endophytic Fungus <i>Curvularia papendorfii</i>, and Isolation of a New Polyhydroxyacid
by: Afra Khiralla, et al.
Published: (2020-09-01)

Pulsed blue light inactivates two strains of human coronavirus
by: Bumah, V.V, et al.
Published: (2021)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020-09-01)

Seroconversion to HCoV-NL63 in Rhesus Macaques
by: Lia van der Hoek, et al.
Published: (2009-10-01)

Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
by: Kathryn E Kistler, et al.
Published: (2021-01-01)

Human Coronaviruses Do Not Transfer Efficiently between Surfaces in the Absence of Organic Materials
by: Matthew Dallner, et al.
Published: (2021-07-01)

Coronavirus HKU1 Infection in the United States
by: Frank Esper, et al.
Published: (2006-05-01)

Evidence of human coroanvirus (229E), in patients with respiratory infection, Iran, 2015: the first report
by: Ali Madhi, et al.
Published: (2016-12-01)

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
by: Homa Nath Sharma, et al.
Published: (2021-09-01)

Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity Against Coronaviruses
by: Andrea Citarella, et al.
Published: (2021-01-01)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
by: Sean A. Lynch, et al.
Published: (2021-08-01)

Artificial Light at Night (ALAN): A Potential Anthropogenic Component for the COVID-19 and HCoVs Outbreak
by: Zeeshan Ahmad Khan, et al.
Published: (2020-09-01)

HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic
by: Elena Rita Simula, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_ed8hh3sdnqmn5t86plgtik6pc3